|
by Banerjee, Srabani, Severn, Melissa
Published 2020
Published 2020
Canadian Agency for Drugs and Technologies in Health
|
by Banerjee, Srabani, Walter, Melissa
Published 2019
Published 2019
Canadian Agency for Drugs and Technologies in Health
|
by Banerjee, Srabani, McCormack, Suzanne
Published 2020
Published 2020
Canadian Agency for Drugs and Technologies in Health
|
by Banerjee, Srabani, McCormack, Suzanne
Published 2020
Published 2020
Canadian Agency for Drugs and Technologies in Health
|
by Banerjee, Srabani, Kaunelis, David
Published 2017
Published 2017
Canadian Agency for Drugs and Technologies in Health
|
Topical antibiotics for infection prevention : a review of the clinical effectiveness and guidelines
by Banerjee, Srabani, Argáez, Charlene
Published 2017
Published 2017
Canadian Agency for Drugs and Technologies in Health
|
by Banerjee, Srabani, McCormack, Suzanne
Published 2019
Published 2019
Canadian Agency for Drugs and Technologies in Health
|
by Banerjee, Srabani, Picheca, Lory
Published 2017
Published 2017
Canadian Agency for Drugs and Technologies in Health
|
by Gauthier, Kasandra, Dulong, Camille, Argáez, Charlene
Published 2019
Published 2019
Canadian Agency for Drugs and Technologies in Health
|
by Banerjee, Srabani, Loshak, Hannah
Published 2019
Published 2019
Canadian Agency for Drugs and Technologies in Health
|
by Banerjee, Srabani, Jones, Sarah
Published 2017
Published 2017
Canadian Agency for Drugs and Technologies in Health
|
by Banerjee, Srabani, Butcher, Robyn
Published 2020
Published 2020
Canadian Agency for Drugs and Technologies in Health
|
by Banerjee, Srabani, Ryce, Andrea
Published 2019
Published 2019
Canadian Agency for Drugs and Technologies in Health
|
by Banerjee, Srabani, Severn, Melissa
Published 2018
Published 2018
Canadian Agency for Drugs and Technologies in Health
|
by Banerjee, Srabani, Ford, Caitlyn
Published 2018
Published 2018
Canadian Agency for Drugs and Technologies in Health
|
by Banerjee, Srabani, McCormack, Suzanne
Published 2019
Published 2019
Canadian Agency for Drugs and Technologies in Health